In subsequent studies: PIONEER-6 and ELIXA the primary endpoints (death from cardiovascular causes, nonfatal myocardial infarction, or nonfatal stroke, hospitalization for unstable angina) were not met in the GLP-1 RAs group, but a significant decrease in glycated hemoglobin was observed
Their benefits are most noticeable in people who have low or borderline B12 levels, absorption challenges, or increased needs
The number of units for 250 mcg of BPC-157 depends on how much diluent you added
One of the ongoing debates about this entire class of medications is whether the effects are mediated solely by weight loss and mitigation of the inflammatory consequences of energy toxicity (read: too many calories) versus other biological effects of these medications
These include: Redness, itching, pain, and rashes Sensitivity at the site of injection Dry mouth Nausea Headaches Lightheadedness Transient fever Based on research involving GH (not ipamorelin) some patients who receive GH therapy may also experience slightly more severe side effects, including: Test subjects with pre-existing conditions such as hypertension or diabetes should not be administered this peptide